(Total Views: 709)
Posted On: 08/23/2017 12:40:10 PM
Post# of 1525
With its current market cap of just 4.6M RXMD is 20xfold undervalued compared to hundreds of listed companies in this sector.
Market cap of a company in this sector (Drugs/Pharmaceutical) easily reaches 4x the P/S ratio...so for 22M revs in 2017 the RXMD pps fair market value, not even taking its constant market expansion into account, should be around 26+ cents.
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
Market cap of a company in this sector (Drugs/Pharmaceutical) easily reaches 4x the P/S ratio...so for 22M revs in 2017 the RXMD pps fair market value, not even taking its constant market expansion into account, should be around 26+ cents.
http://pages.stern.nyu.edu/~adamodar/New_Home...sdata.html
(0)
(0)Scroll down for more posts ▼
